Menu

Selectivity data for probe PF-04418948 and control PF-04475866


Jump to control PDSP data

PF-04418948


Compound concentration: 10 µM
Receptor HGNC target name Inhibition [%] (Primary experimental value) Ki [nM] (Secondary experimental value) pKi
M3 CHRM3 19.22
Sigma 1 SIGMAR1 21.07
DAT SLC6A3 -14.46
M2 CHRM2 16.71
SERT SLC6A4 -6.83
5-HT1A HTR1A -22.74
GABAA/BZP 18.70
D3 DRD3 32.96
D4 DRD4 8.76
D5 DRD5 -2.51
GABAA -1.97
H1 HRH1 -11.53
H2 HRH2 3.00
KOR OPRK1 16.41
MOR OPRM1 1.07
5-HT1B HTR1B -11.25
5-HT1D HTR1D -24.02
5-HT1E HTR1E 10.97
5-HT6 HTR6 -6.47
5-HT7A HTR7 -9.26
Beta2 ADRB2 -17.45
D1 DRD1 -26.64
D2 DRD2 -23.45
DOR OPRD1 5.07
H3 HRH3 -15.34
M1 CHRM1 -0.03
M5 CHRM5 -7.44
Beta1 ADRB1 -12.18
Beta3 ADRB3 -19.86
H4 HRH4 -17.71
5-HT2A HTR2A 6.25
5-HT2B HTR2B -0.11
5-HT2C HTR2C 12.35
5-HT3 HTR3A 0.08
5-HT5A HTR5A -8.97
Alpha1A ADRA1A 2.52
Alpha1B ADRA1B -11.36
Alpha1D ADRA1D -3.76
Alpha2A ADRA2A 21.80
Alpha2B ADRA2B 9.24
Alpha2C ADRA2C 9.72
M4 CHRM4 -18.57
NET SLC6A2 11.01
Sigma 2 TMEM97 -1.29
GABA/PBR -30.46

PF-04475866


Compound concentration: 10 µM
Receptor HGNC target name Inhibition [%] (Primary experimental value) Ki [nM] (Secondary experimental value) pKi
GABA/PBR 16.30
Beta1 ADRB1 -6.66
Beta3 ADRB3 -13.27
H4 HRH4 -26.19 > 10000.00 < 5.00
5-HT1B HTR1B -16.87
5-HT1D HTR1D -24.94
5-HT1E HTR1E 12.21
5-HT6 HTR6 -2.64
5-HT7A HTR7 -12.04
Beta2 ADRB2 -14.97
D1 DRD1 -52.32 > 10000.00 < 5.00
D2 DRD2 -29.44
DOR OPRD1 -5.22
H3 HRH3 -19.98
M1 CHRM1 -0.69
M5 CHRM5 -0.33
5-HT1A HTR1A -18.08
GABAA/BZP -5.33
D3 DRD3 3.89
D4 DRD4 -7.87
D5 DRD5 2.20
GABAA -8.88
H1 HRH1 -4.38
H2 HRH2 15.69
KOR OPRK1 -9.45
MOR OPRM1 -11.90
5-HT2A HTR2A -2.23
5-HT2B HTR2B -2.50
5-HT2C HTR2C 30.19
5-HT3 HTR3A 16.59
5-HT5A HTR5A -14.33
Alpha1A ADRA1A -4.09
Alpha1B ADRA1B -14.57
Alpha1D ADRA1D 5.00
Alpha2A ADRA2A 14.22
Alpha2B ADRA2B 12.13
Alpha2C ADRA2C 11.28
M4 CHRM4 -15.97
NET SLC6A2 16.75
Sigma 2 TMEM97 -12.24
DAT SLC6A3 6.07
M2 CHRM2 26.66
SERT SLC6A4 -6.29
Sigma 1 SIGMAR1 20.31
M3 CHRM3 27.93

Jump to PDSP top

Primary results are shown as '% Ctrl', i.e. the negative control (DMSO) is equal 100% control and the positive control (control compound) is equal 0% control. For compounds showing less than 50% of control in the primary screening assay, a Kd will be determined. Note: It cannot be excluded that 0 % control values are due to assay artefacts.
View assay details

Jump to control KinomeScan data

PF-04418948


HGNC target name DiscoverX gene symbol of kinase % Control Compound Concentration [nM] Kd [nM]
AAK1 AAK1 100.0 1000
ABL1 ABL1-phosphorylated 100.0 1000
ABL2 ABL2 100.0 1000
ACVR1 ACVR1 100.0 1000
ACVR1B ACVR1B 78.0 1000
ACVR2A ACVR2A 100.0 1000
ACVR2B ACVR2B 100.0 1000
ACVRL1 ACVRL1 93.0 1000
COQ8A ADCK3 100.0 1000
COQ8B ADCK4 100.0 1000
AKT1 AKT1 100.0 1000
AKT2 AKT2 100.0 1000
AKT3 AKT3 88.0 1000
ALK ALK(L1196M) 100.0 1000
PRKAA1 AMPK-alpha1 100.0 1000
PRKAA2 AMPK-alpha2 28.0 1000
ANKK1 ANKK1 86.0 1000
NUAK1 ARK5 94.0 1000
MAP3K5 ASK1 98.0 1000
MAP3K6 ASK2 95.0 1000
AURKA AURKA 100.0 1000
AURKB AURKB 100.0 1000
AURKC AURKC 98.0 1000
AXL AXL 100.0 1000
BMP2K BIKE 100.0 1000
BLK BLK 93.0 1000
BMPR1A BMPR1A 88.0 1000
BMPR1B BMPR1B 95.0 1000
BMPR2 BMPR2 87.0 1000
BMX BMX 87.0 1000
BRAF BRAF(V600E) 100.0 1000
PTK6 BRK 99.0 1000
BRSK1 BRSK1 85.0 1000
BRSK2 BRSK2 100.0 1000
BTK BTK 84.0 1000
BUB1 BUB1 100.0 1000
CAMK1 CAMK1 100.0 1000
PNCK CAMK1B 100.0 1000
CAMK1D CAMK1D 100.0 1000
CAMK1G CAMK1G 100.0 1000
CAMK2A CAMK2A 100.0 1000
CAMK2B CAMK2B 100.0 1000
CAMK2D CAMK2D 100.0 1000
CAMK2G CAMK2G 100.0 1000
CAMK4 CAMK4 88.0 1000
CAMKK1 CAMKK1 91.0 1000
CAMKK2 CAMKK2 94.0 1000
CASK CASK 91.0 1000
CDK11B CDC2L1 100.0 1000
CDK11A CDC2L2 100.0 1000
CDK13 CDC2L5 100.0 1000
CDK19 CDK11 95.0 1000
CDK2 CDK2 91.0 1000
CDK3 CDK3 83.0 1000
CDK4 CDK4-cyclinD3 100.0 1000
CDK5 CDK5 100.0 1000
CDK7 CDK7 100.0 1000
CDK8 CDK8 94.0 1000
CDK9 CDK9 100.0 1000
CDKL1 CDKL1 100.0 1000
CDKL2 CDKL2 89.0 1000
CDKL3 CDKL3 89.0 1000
CDKL5 CDKL5 97.0 1000
CHEK1 CHEK1 87.0 1000
CHEK2 CHEK2 93.0 1000
CIT CIT 100.0 1000
CLK1 CLK1 79.0 1000
CLK2 CLK2 100.0 1000
CLK3 CLK3 99.0 1000
CLK4 CLK4 100.0 1000
CSF1R CSF1R-autoinhibited 75.0 1000
CSK CSK 100.0 1000
CSNK1A1 CSNK1A1 100.0 1000
CSNK1A1L CSNK1A1L 100.0 1000
CSNK1D CSNK1D 100.0 1000
CSNK1E CSNK1E 94.0 1000
CSNK1G1 CSNK1G1 94.0 1000
CSNK1G2 CSNK1G2 100.0 1000
CSNK1G3 CSNK1G3 100.0 1000
CSNK2A1 CSNK2A1 100.0 1000
CSNK2A2 CSNK2A2 100.0 1000
MATK CTK 100.0 1000
DAPK1 DAPK1 100.0 1000
DAPK2 DAPK2 98.0 1000
DAPK3 DAPK3 100.0 1000
DCLK1 DCAMKL1 100.0 1000
DCLK2 DCAMKL2 100.0 1000
DCLK3 DCAMKL3 98.0 1000
DDR1 DDR1 100.0 1000
DDR2 DDR2 100.0 1000
MAP3K12 DLK 97.0 1000
DMPK DMPK 76.0 1000
CDC42BPG DMPK2 91.0 1000
STK17A DRAK1 81.0 1000
STK17B DRAK2 100.0 1000
DYRK1A DYRK1A 100.0 1000
DYRK1B DYRK1B 100.0 1000
DYRK2 DYRK2 84.0 1000
EGFR EGFR(T790M) 100.0 1000
EIF2AK1 EIF2AK1 94.0 1000
EPHA1 EPHA1 83.0 1000
EPHA2 EPHA2 100.0 1000
EPHA3 EPHA3 92.0 1000
EPHA4 EPHA4 100.0 1000
EPHA5 EPHA5 78.0 1000
EPHA6 EPHA6 100.0 1000
EPHA7 EPHA7 100.0 1000
EPHA8 EPHA8 100.0 1000
EPHB1 EPHB1 100.0 1000
EPHB2 EPHB2 100.0 1000
EPHB3 EPHB3 99.0 1000
EPHB4 EPHB4 95.0 1000
EPHB6 EPHB6 100.0 1000
ERBB2 ERBB2 100.0 1000
ERBB3 ERBB3 89.0 1000
ERBB4 ERBB4 100.0 1000
MAPK3 ERK1 100.0 1000
MAPK1 ERK2 97.0 1000
MAPK6 ERK3 88.0 1000
MAPK4 ERK4 100.0 1000
MAPK7 ERK5 100.0 1000
MAPK15 ERK8 74.0 1000
ERN1 ERN1 80.0 1000
PTK2 FAK 100.0 1000
FER FER 74.0 1000
FES FES 100.0 1000
FGFR1 FGFR1 100.0 1000
FGFR2 FGFR2 100.0 1000
FGFR3 FGFR3(G697C) 88.0 1000
FGFR4 FGFR4 100.0 1000
FGR FGR 96.0 1000
FLT1 FLT1 100.0 1000
FLT3 FLT3-autoinhibited 96.0 1000
FLT4 FLT4 75.0 1000
FRK FRK 100.0 1000
FYN FYN 100.0 1000
GAK GAK 88.0 1000
EIF2AK4 GCN2(Kin.Dom.2,S808G) 100.0 1000
GRK1 GRK1 100.0 1000
GRK2 GRK2 72.0 1000
GRK3 GRK3 67.0 1000
GRK4 GRK4 100.0 1000
GRK7 GRK7 93.0 1000
GSK3A GSK3A 96.0 1000
GSK3B GSK3B 100.0 1000
HASPIN HASPIN 100.0 1000
HCK HCK 100.0 1000
HIPK1 HIPK1 100.0 1000
HIPK2 HIPK2 78.0 1000
HIPK3 HIPK3 100.0 1000
HIPK4 HIPK4 100.0 1000
MAP4K1 HPK1 95.0 1000
HUNK HUNK 100.0 1000
CILK1 ICK 78.0 1000
IGF1R IGF1R 100.0 1000
CHUK IKK-alpha 100.0 1000
IKBKB IKK-beta 100.0 1000
IKBKE IKK-epsilon 95.0 1000
INSR INSR 93.0 1000
INSRR INSRR 67.0 1000
IRAK1 IRAK1 100.0 1000
IRAK3 IRAK3 100.0 1000
IRAK4 IRAK4 87.0 1000
ITK ITK 100.0 1000
JAK1 JAK1(JH2domain-pseudokinase) 96.0 1000
JAK2 JAK2(JH1domain-catalytic) 89.0 1000
JAK3 JAK3(JH1domain-catalytic) 100.0 1000
MAPK8 JNK1 76.0 1000
MAPK9 JNK2 100.0 1000
MAPK10 JNK3 85.0 1000
KIT KIT-autoinhibited 100.0 1000
LATS1 LATS1 87.0 1000
LATS2 LATS2 90.0 1000
LCK LCK 80.0 1000
LIMK1 LIMK1 100.0 1000
LIMK2 LIMK2 90.0 1000
STK11 LKB1 100.0 1000
STK10 LOK 100.0 1000
LRRK2 LRRK2(G2019S) 84.0 1000
LTK LTK 100.0 1000
LYN LYN 85.0 1000
MAP3K13 LZK 100.0 1000
MAK MAK 100.0 1000
MAP3K1 MAP3K1 100.0 1000
MAP3K15 MAP3K15 94.0 1000
MAP3K2 MAP3K2 96.0 1000
MAP3K3 MAP3K3 97.0 1000
MAP3K4 MAP3K4 65.0 1000
MAP4K2 MAP4K2 100.0 1000
MAP4K3 MAP4K3 100.0 1000
MAP4K4 MAP4K4 100.0 1000
MAP4K5 MAP4K5 86.0 1000
MAPKAPK2 MAPKAPK2 100.0 1000
MAPKAPK5 MAPKAPK5 76.0 1000
MARK1 MARK1 100.0 1000
MARK2 MARK2 91.0 1000
MARK3 MARK3 94.0 1000
MARK4 MARK4 100.0 1000
MAST1 MAST1 100.0 1000
MAP2K1 MEK1 100.0 1000
MAP2K2 MEK2 100.0 1000
MAP2K3 MEK3 95.0 1000
MAP2K4 MEK4 90.0 1000
MAP2K5 MEK5 93.0 1000
MAP2K6 MEK6 100.0 1000
MELK MELK 86.0 1000
MERTK MERTK 80.0 1000
MET MET(Y1235D) 91.0 1000
MINK1 MINK 100.0 1000
MAP2K7 MKK7 79.0 1000
MKNK1 MKNK1 93.0 1000
MKNK2 MKNK2 96.0 1000
MYLK3 MLCK 100.0 1000
MAP3K9 MLK1 100.0 1000
MAP3K10 MLK2 100.0 1000
MAP3K11 MLK3 79.0 1000
CDC42BPA MRCKA 100.0 1000
CDC42BPB MRCKB 100.0 1000
STK4 MST1 100.0 1000
MST1R MST1R 100.0 1000
STK3 MST2 100.0 1000
STK24 MST3 85.0 1000
STK26 MST4 100.0 1000
MTOR MTOR 100.0 1000
MUSK MUSK 72.0 1000
MYLK MYLK 84.0 1000
MYLK2 MYLK2 100.0 1000
MYLK4 MYLK4 100.0 1000
MYO3A MYO3A 100.0 1000
MYO3B MYO3B 71.0 1000
STK38 NDR1 98.0 1000
STK38L NDR2 86.0 1000
NEK1 NEK1 100.0 1000
NEK10 NEK10 100.0 1000
NEK11 NEK11 93.0 1000
NEK2 NEK2 100.0 1000
NEK3 NEK3 100.0 1000
NEK4 NEK4 94.0 1000
NEK5 NEK5 100.0 1000
NEK6 NEK6 100.0 1000
NEK7 NEK7 100.0 1000
NEK9 NEK9 100.0 1000
MAP3K14 NIK 82.0 1000
NIM1K NIM1 100.0 1000
NLK NLK 94.0 1000
OXSR1 OSR1 100.0 1000
MAPK14 p38-alpha 100.0 1000
MAPK11 p38-beta 78.0 1000
MAPK13 p38-delta 100.0 1000
MAPK12 p38-gamma 100.0 1000
PAK1 PAK1 87.0 1000
PAK2 PAK2 83.0 1000
PAK3 PAK3 94.0 1000
PAK4 PAK4 94.0 1000
PAK6 PAK6 100.0 1000
PAK5 PAK7 100.0 1000
CDK16 PCTK1 100.0 1000
CDK17 PCTK2 100.0 1000
CDK18 PCTK3 98.0 1000
PDGFRA PDGFRA 100.0 1000
PDGFRB PDGFRB 100.0 1000
PDPK1 PDPK1 100.0 1000
CDPK1 PFCDPK1(P.falciparum) 100.0 1000
PK5 PFPK5(P.falciparum) 97.0 1000
CDK15 PFTAIRE2 100.0 1000
CDK14 PFTK1 100.0 1000
PHKG1 PHKG1 100.0 1000
PHKG2 PHKG2 100.0 1000
PIK3C2B PIK3C2B 100.0 1000
PIK3C2G PIK3C2G 100.0 1000
PIK3CA PIK3CA(Q546K) 42.0 1000
PIK3CB PIK3CB 100.0 1000
PIK3CD PIK3CD 100.0 1000
PIK3CG PIK3CG 100.0 1000
PI4KB PIK4CB 100.0 1000
PIKFYVE PIKFYVE 91.0 1000
PIM1 PIM1 96.0 1000
PIM2 PIM2 100.0 1000
PIM3 PIM3 98.0 1000
PIP5K1A PIP5K1A 100.0 1000
PIP5K1C PIP5K1C 84.0 1000
PIP4K2B PIP5K2B 74.0 1000
PIP4K2C PIP5K2C 100.0 1000
PRKACA PKAC-alpha 100.0 1000
PRKACB PKAC-beta 100.0 1000
PKMYT1 PKMYT1 100.0 1000
PKN1 PKN1 100.0 1000
PKN2 PKN2 100.0 1000
PKNB PKNB(M.tuberculosis) 88.0 1000
PLK1 PLK1 100.0 1000
PLK2 PLK2 100.0 1000
PLK3 PLK3 95.0 1000
PLK4 PLK4 82.0 1000
PRKCD PRKCD 100.0 1000
PRKCE PRKCE 100.0 1000
PRKCH PRKCH 100.0 1000
PRKCI PRKCI 100.0 1000
PRKCQ PRKCQ 100.0 1000
PRKD1 PRKD1 96.0 1000
PRKD2 PRKD2 93.0 1000
PRKD3 PRKD3 91.0 1000
PRKG1 PRKG1 100.0 1000
PRKG2 PRKG2 85.0 1000
EIF2AK2 PRKR 100.0 1000
PRKX PRKX 90.0 1000
PRPF4B PRP4 100.0 1000
PTK2B PYK2 100.0 1000
SIK3 QSK 72.0 1000
RAF1 RAF1 100.0 1000
RET RET(V804M) 94.0 1000
RIOK1 RIOK1 100.0 1000
RIOK2 RIOK2 100.0 1000
RIOK3 RIOK3 97.0 1000
RIPK1 RIPK1 100.0 1000
RIPK2 RIPK2 100.0 1000
RIPK4 RIPK4 66.0 1000
DSTYK RIPK5 100.0 1000
ROCK1 ROCK1 100.0 1000
ROCK2 ROCK2 100.0 1000
ROS1 ROS1 81.0 1000
RPS6KA4 RPS6KA4(Kin.Dom.2-C-terminal) 85.0 1000
RPS6KA5 RPS6KA5(Kin.Dom.2-C-terminal) 96.0 1000
RPS6KA1 RSK1(Kin.Dom.2-C-terminal) 100.0 1000
RPS6KA3 RSK2(Kin.Dom.2-C-terminal) 85.0 1000
RPS6KA2 RSK3(Kin.Dom.2-C-terminal) 100.0 1000
RPS6KA6 RSK4(Kin.Dom.2-C-terminal) 78.0 1000
RPS6KB1 S6K1 100.0 1000
SBK1 SBK1 100.0 1000
SGK1 SGK 81.0 1000
SBK3 SgK110 100.0 1000
SGK2 SGK2 87.0 1000
SGK3 SGK3 100.0 1000
SIK1 SIK 97.0 1000
SIK2 SIK2 100.0 1000
SLK SLK 85.0 1000
NUAK2 SNARK 92.0 1000
SNRK SNRK 100.0 1000
SRC SRC 100.0 1000
SRMS SRMS 100.0 1000
SRPK1 SRPK1 72.0 1000
SRPK2 SRPK2 84.0 1000
SRPK3 SRPK3 100.0 1000
STK16 STK16 88.0 1000
STK33 STK33 98.0 1000
STK35 STK35 100.0 1000
STK36 STK36 89.0 1000
STK39 STK39 55.0 1000
SYK SYK 64.0 1000
MAP3K7 TAK1 96.0 1000
TAOK1 TAOK1 100.0 1000
TAOK2 TAOK2 100.0 1000
TAOK3 TAOK3 35.0 1000
TBK1 TBK1 100.0 1000
TEC TEC 100.0 1000
TESK1 TESK1 98.0 1000
TGFBR1 TGFBR1 100.0 1000
TGFBR2 TGFBR2 100.0 1000
TIE1 TIE1 100.0 1000
TEK TIE2 100.0 1000
TLK1 TLK1 87.0 1000
TLK2 TLK2 100.0 1000
TNIK TNIK 61.0 1000
TNK1 TNK1 100.0 1000
TNK2 TNK2 100.0 1000
TNNI3K TNNI3K 100.0 1000
NTRK1 TRKA 71.0 1000
NTRK2 TRKB 100.0 1000
NTRK3 TRKC 98.0 1000
TRPM6 TRPM6 98.0 1000
TSSK1B TSSK1B 100.0 1000
TSSK3 TSSK3 82.0 1000
TTK TTK 100.0 1000
TXK TXK 100.0 1000
TYK2 TYK2(JH2domain-pseudokinase) 100.0 1000
TYRO3 TYRO3 100.0 1000
ULK1 ULK1 92.0 1000
ULK2 ULK2 89.0 1000
ULK3 ULK3 86.0 1000
KDR VEGFR2 100.0 1000
PIK3C3 VPS34 100.0 1000
VRK2 VRK2 100.0 1000
WEE1 WEE1 100.0 1000
WEE2 WEE2 100.0 1000
WNK1 WNK1 84.0 1000
WNK2 WNK2 84.0 1000
WNK3 WNK3 93.0 1000
WNK4 WNK4 79.0 1000
STK32A YANK1 97.0 1000
STK32B YANK2 100.0 1000
STK32C YANK3 100.0 1000
YES1 YES 100.0 1000
STK25 YSK1 100.0 1000
MAP3K19 YSK4 82.0 1000
MAP3K20 ZAK 100.0 1000
ZAP70 ZAP70 99.0 1000

Jump to DiscoverX top

PF-04418948

Ligand profiling has been performed at 10 µM probe concentration with IC50 and Ki follow up for specific targets.

Conclusion: Closest off-targets at 10 µM are LTB4 (IC50 = 9.7 µM), ML2 (IC50 = 0.53 µM) and PDE3 (IC50 = 3.5 µM).

Target protein HGNC name Species % inhibition at 10 µM IC50 [nM] Ki [nM]
5-HT transporter (h) SLC6A4 Homo sapiens -8.0
5-HT1A (h) HTR1A Homo sapiens 6.0
5-HT1B HTR1B Homo sapiens -7.0
5-HT1D HTR1D -10.0
5-HT2A (h) HTR2A 0.0
5-HT2A (h) (agonist site) HTR2A Homo sapiens -15.0
5-HT2B (h) (agonist site/DOI) HTR2B Homo sapiens 13.0
5-HT2C (h) HTR2C Homo sapiens 8.0
5-HT2C (h) (agonist site) HTR2C Homo sapiens -6.0
5-HT3 (h) HTR3A Homo sapiens -6.0
5-HT4e (h) HTR4 Homo sapiens -14.0
5-HT6 (h) HTR6 Homo sapiens 0.0
5-HT7 (h) HTR7 Homo sapiens -2.0
A1 (h) ADORA1 Homo sapiens -2.0
A2A (h) ADORA2A Homo sapiens -9.0
A3 (h) ADORA3 Homo sapiens -10.0
Abl kinase (h) ABL1 Homo sapiens 9.0
ACE (h) ACE Homo sapiens 14.0
Acetylcholinesterase (h) ACHE Homo sapiens 45.0
alpha 1 (non- selective) 9.0
alpha 2A (h) ADRA2A Homo sapiens 26.0
alpha 2B (h) ADRA2B Homo sapiens 1.0
alpha 2C (h) ADRA2C Homo sapiens 4.0
AMPA -13.0
Androgen (h) (AR) AR Homo sapiens 0.0
AT1 (h) AGTR1 Homo sapiens 1.0
ATPase (Na+/K+) Homo sapiens 5.0
beta 1 (h) ADRB1 Homo sapiens 9.0
beta 2 (h) ADRB2 Homo sapiens -4.0
beta 3 (h) ADRB3 Homo sapiens 3.0
Ca2+ channel (L, DHP site) Homo sapiens -3.0
Ca2+ channel (L, diltiazem site) Homo sapiens 6.0
Ca2+ channel (L, verapamil site) Homo sapiens -5.0
Ca2+ channel (N) Homo sapiens -7.0
CaMK2alpha (h) CAMK2A Homo sapiens 5.0
Carbonic anhydrase II (h) CA2 Homo sapiens 9.0
Caspase-3 (h) CASP3 Homo sapiens 0.0
CB1 (h) CNR1 Homo sapiens 0.0
CB2 (h) CNR2 Homo sapiens 0.0
CCKA (h) (CCK1) CCKAR Homo sapiens 29.0
CCKB (h) (CCK2) CCKBR Homo sapiens -8.0
Choline transporter (h) (CHT1) SLC5A7 Homo sapiens 4.0
Cl- channel 19.0
COX1 (h) PTGS1 Homo sapiens -25.0
COX2 (h) PTGS2 Homo sapiens 2.0
CXCR4 (h) CXCR4 Homo sapiens 4.0
CYP2C19 inhibition CYP2C19 5.0
CYP2C9 inhibition CYP2C9 41.0
CYP2D6 inhibition CYP2D6 18.0
CYP3A4 inhibition CYP3A4 17.0
D1 (h) DRD1 Homo sapiens 5.0
D2S (h) DRD2 Homo sapiens -2.0
D2S (h) (agonist site) DRD2 Homo sapiens -6.0
D3 (h) DRD3 Homo sapiens 1.0
D4.4 (h) DRD4 Homo sapiens -8.0
DA transporter (h) SLC6A3 Homo sapiens 11.0
delta 2 (h) (DOP) OPRD1 Homo sapiens 0.0
ETA (h) EDNRA Homo sapiens 3.0
ETB (h) EDNRB Homo sapiens -1.0
FLT-1 kinase (h) (VEGFR1) FLT1 Homo sapiens 9.0
GABAA BZD (central) 10.0
GABA transporter SLC6A1 14.0
GABAA 16.0
GABAB (1b) (h) GABBR1 Homo sapiens -21.0
Ghrelin (h) (GHS) GHRL Homo sapiens -6.0
GR (h) NR3C1 Homo sapiens -1.0
Glycine (strychnine-insensitive) 11.0
H1 (h) HRH1 Homo sapiens 0.0
H2 (h) HRH2 Homo sapiens 3.0
H3 (h) HRH3 Homo sapiens 10.0
H4 (h) HRH4 Homo sapiens -4.0
I1 GNAI1 -14.0
Kainate GRIK2 -15.0
kappa (KOP) OPRK1 Homo sapiens 46.0
LTB4 (h) (BLT1) LTB4R Homo sapiens 51.0 9700.00 4800.00
LTD4 (h) (CysLT1) CYSLTR1 Homo sapiens 2.0
Lyn kinase (h) LYN Homo sapiens 2.0
M1 (h) CHRM1 Homo sapiens 9.0
M2 (h) CHRM2 Homo sapiens 1.0
M3 (h) CHRM3 Homo sapiens 1.0
M4 (h) CHRM4 Homo sapiens 0.0
M5 (h) CHRM5 Homo sapiens 1.0
MAO-A MAOA 3.0
MC1 MC1R 6.0
MC3 (h) MC3R Homo sapiens -11.0
MC4 (h) MC4R Homo sapiens 8.0
MCH1 (h) MCHR1 Homo sapiens -13.0
ML1 MCOLN1 -3.0
ML2 (MT3) NQO2 93.0 530.00 520.00
MMP-9 (h) MMP9 Homo sapiens 10.0
Motilin (h) MLNR Homo sapiens -5.0
mu (h) (MOP) (agonist site) OPRM1 Homo sapiens -7.0
N (muscle-type) (h) CHRNA4 Homo sapiens -10.0
N (neuronal) (alpha -BGTX-insensitive) (alpha 4 beta 2) CHRNA1 -10.0
Na+ channel (site 2) 9.0
NE transporter (h) SLC6A2 Homo sapiens -2.0
NK1 (h) TACR1 Homo sapiens 3.0
NK2 (h) TACR2 Homo sapiens 0.0
NMDA 1.0
p38 alpha kinase (h) MAPK14 Homo sapiens -1.0
PCP PRCP -6.0
PDE11 (h) PDE11A Homo sapiens 14.0
PDE2 (h) PDE2A Homo sapiens 5.0
PDE3 (h) Homo sapiens 78.0 3500.00
PDE4 (h) Homo sapiens 8.0
PDE5 (h) PDE5A Homo sapiens 6.0
PDE6 3.0
PPAR gamma (h) PPARG Homo sapiens 14.0
Rolipram 3.0
sigma (non-selective) 0.0
SK+Ca channel -1.0
sst4 (h) SSTR4 Homo sapiens 0.0
TH TH -10.0
TNF-alpha (h) TNF Homo sapiens -1.0
TXA2/P GH2 (h)(TP) TBXA2R Homo sapiens 0.0
UT1 (h) SLC14A1 Homo sapiens 14.0
V1a (h) AVPR1A Homo sapiens -3.0
V2 (h) AVPR2 Homo sapiens -1.0
VIP1 (h) (VPAC1) VIPR1 Homo sapiens -13.0
Y1 (h) NPY1R Homo sapiens 1.0
ZAP70 kinase (h) ZAP70 Homo sapiens 9.0